{"id":"NCT00206336","sponsor":"Baylor College of Medicine","briefTitle":"An Open-label Study to Determine the Efficacy and Safety of Topiramate in the Treatment of Tourette Syndrome.","officialTitle":"An Open-label Study to Determine the Efficacy and Safety of Topiramate in the Treatment of Tourette Syndrome (CAPSS-286)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2004-10","primaryCompletion":"2008-12","completion":"2008-12","firstPosted":"2005-09-21","resultsPosted":"2017-11-06","lastUpdate":"2017-11-06"},"enrollment":20,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Tourette Syndrome"],"interventions":[{"type":"DRUG","name":"Topiramate (drug)","otherNames":["Topamax"]}],"arms":[{"label":"topiramate","type":"EXPERIMENTAL"}],"summary":"Previous studies using topiramate in Tourette subjects have shown that with the use of this medication subjects report that their tics get better. The purpose of this study is to study if topiramate improves the symptoms of Tourette syndrome, such as motor tics, or other associated symptoms such as attention or obsessive-compulsive problems.","primaryOutcome":{"measure":"Change in TTS","timeFrame":"baseline to Day 70","effectByArm":[{"arm":"Topiramate","deltaMin":-14.29,"sd":10.47}],"pValues":[]},"eligibility":{"minAge":"7 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["19726418"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":20},"commonTop":["headache","cognitive slowing"]}}